Indication:

Indicated for the treatment of post menopausal women with hormone receptor positive breast cancer. . The safety and efficacy of neoadjuvant use of Letrozole has not been established. Letrozole is not indicated in hormone receptor negative disease.

Generic Name: Letrozole

Strength: 2.5mg

Dosage: Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description: Yellow, round, biconvex, film-coated tablet plain on both sides

Segment :B

Innovator: Femara ®

PBSListed: Yes

RPBSlisted: No

Schedule: S4

Storage Conditions: Store below 25 degrees Celsius

Active Ingredients: letrozole 2.5mg

Warnings: